A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study of the TAK 491 Plus Chlorthalidone Fixed-Dose Combination Compared With TAK-491 and Hydrochlorothiazide Coadministration Therapy in Subjects With Moderate to Severe Essential Hypertension

Name: A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study of the TAK 491 Plus Chlorthalidone Fixed-Dose Combination Compared With TAK-491 and Hydrochlorothiazide Coadministration Therapy in Subjects With Moderate to Severe Essential Hypertension
Creator: Vivli
Published: 2018-10-27T12:24:45+08:00

DataCite Commons2024-12-02 更新2026-05-07 收录

高血压药物临床试验

糖尿病药物疗效比较

数据链接：

https://search.vivli.org/doiLanding/studies/00002504/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to compare the antihypertensive effect of chlorthalidone vs hydrochlorothiazide when each is used with azilsartan medoxomil, once daily (QD), in participants with moderate to severe essential hypertension.

提供机构：

Vivli

创建时间：

2018-10-27